CYPHERPUNK TECHNOLOGIES INC

CypherPunk Technologies: Nasdaq Biotech Innovator Driving Health Care Breakthroughs

CypherPunk Technologies Inc. is a Nasdaq‑listed biotech that’s pushing front‑line health innovations, attracting investors amid market volatility and a $244M cap.

15/09/2026, 16:26

2 minutes to read

Cypherpunk Technologies: Innovating Cancer Care Amid Market Challenges

Explore CYPHERPUNK Technologies’ rise as a biotech leader in cancer therapeutics, its global reach from Cambridge, and investment outlook in this in‑depth profile.

12/09/2026, 21:50

2 minutes to read

Cypherpunk Raises $33M, Targets 18% of Zcash Hashrate to Boost Privacy Mining

Cypherpunk Technologies boosts its Zcash mining share to ~18 % after a $33 M Winklevoss Capital deal, raising analyst targets and positioning for privacy‑tech growth.

22/08/2026, 04:40

4 minutes to read

Cypherpunk Technologies Boosts Digital‑Asset Treasury and Leap Therapeutics’ FDA Phase‑3 Momentum

Cypherpunk Technologies posts Q2 2026 gains: $0.68 a share, expanded ZEC holdings, FDA‑aligned Phase 3 for Leap Therapeutics, and breakthrough DeFianCe results that could drive future upside.

12/08/2026, 13:13

3 minutes to read